Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions

References

• Baumann P, Nyman J, Hoyer M, et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol. 2008;88:359–367.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070–1076.
   PubMed Web of Science ®Google Scholar
• Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. JCO. 2006;24:4833–4839.
   PubMed Web of Science ®Google Scholar
• Forquer JA, Fakiris AJ, Timmerman RD, et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol. 2009;93:408–413.
   PubMed Web of Science ®Google Scholar
• Schierle C, Winograd JM. Radiation-induced brachial plexopathy: review. Complication without a cure. J Reconstr Microsurg. 2004;20:149–152.
   PubMed Web of Science ®Google Scholar
• Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin. 2010;28:217–234.
   PubMed Web of Science ®Google Scholar
• Delanian S, Lefaix JL, Pradat PF. Radiation-induced neuropathy in cancer survivors. Radiother Oncol. 2012;105:273–282.
   PubMed Web of Science ®Google Scholar
• Friberg S, Ruden BI. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast. Acta Oncol. 2009;48:822–831.
   PubMed Web of Science ®Google Scholar
• Harper CM, Jr., Thomas JE, Cascino TL, et al. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology. 1989;39:502–506.
   PubMed Web of Science ®Google Scholar
• Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: 100 cases. Neurology. 1981;31:45–50.
   PubMed Web of Science ®Google Scholar
• Mondrup K, Olsen NK, Pfeiffer P, et al. Clinical and electrodiagnostic findings in breast cancer patients with radiation-induced brachial plexus neuropathy. Acta Neurol Scand. 1990;81:153–158.
   PubMed Web of Science ®Google Scholar
• Olsen NK, Pfeiffer P, Johannsen L, et al. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys. 1993;26:43–49.
   PubMed Web of Science ®Google Scholar
• Amini A, Yang J, Williamson R, et al. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys. 2012;82:e391–e398.
   PubMed Web of Science ®Google Scholar
• Eblan MJ, Corradetti MN, Lukens JN, et al. Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications. Int J Radiat Oncol Biol Phys. 2013;85:175–181.
   PubMed Web of Science ®Google Scholar
• Stoll BA, Andrews JT. Radiation-induced peripheral neuropathy. Br Med J. 1966;1:834–837.
   PubMed Web of Science ®Google Scholar
• Ferrante MA. Brachial plexopathies: classification, causes, and consequences. Muscle Nerve. 2004;30:547–568.
   PubMed Web of Science ®Google Scholar
• Kang KH, Okoye CC, Patel RB, et al. Complications from stereotactic body radiotherapy for lung cancer. Cancers. 2015;7:981–1004.
   PubMed Web of Science ®Google Scholar
• De Rose F, Franceschini D, Reggiori G, et al. Organs at risk in lung SBRT. Phys Med. 2017;44:131–138.
   PubMed Web of Science ®Google Scholar
• Hanna GG, Murray L, Patel R, et al. UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol. 2018;30:5–14.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. JCO. 2009;27:3290–3296.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–795.
   PubMed Web of Science ®Google Scholar
• Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847–852.
   PubMed Web of Science ®Google Scholar
• Wennberg B, Lax I. The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model. Acta Oncol. 2013;52:902–909.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122.
   PubMed Web of Science ®Google Scholar
• Mutter RW, Lok BH, Dutta PR, et al. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma. Radiat Oncol. 2013;8:173.
   PubMed Web of Science ®Google Scholar
• Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;72:967–971.
   PubMed Web of Science ®Google Scholar
• Chang JY, Li QQ, Xu QY, et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". Int J Radiat Oncol Biol Phys. 2014;88:1120–1128.
   PubMed Web of Science ®Google Scholar
• Stubblefield MD, Ibanez K, Riedel ER, et al. Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors. Neurosurg Focus. 2017;42:E12.
   PubMed Web of Science ®Google Scholar
• Sood SS, McClinton C, Badkul R, et al. Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: dosimetric analysis and preliminary clinical outcomes. Adv Radiat Oncol. 2018;3:81–86.
   PubMedGoogle Scholar
• Sharma M, Bennett EE, Rahmathulla G, et al. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk. Neurosurg Focus. 2017;42:E14.
   PubMed Web of Science ®Google Scholar
• https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf [last accessed 19 March 2019].
   Google Scholar
• Hall WH, Guiou M, Lee NY, et al. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2008;72:1362–1367.
   PubMed Web of Science ®Google Scholar
• Min M, Roos D, Keating E, et al. External evaluation of the Radiation Therapy Oncology Group brachial plexus contouring protocol: several issues identified. J Med Imaging Radiat Oncol. 2014;58:360–368.
   PubMed Web of Science ®Google Scholar